
|Articles|October 12, 2012
Trading Away the Medicines of Tomorrow
Author(s)Mike Hennessy
Advertisement
One of the major issues being negotiated right now the amount of protection for the intellectual property of pharmaceutical and biotech companies. And failure to protect the intellectual property rights will actually hurt patients more than the companies.
Click
Newsletter
Stay informed and empowered with Medical Economics enewsletter, delivering expert insights, financial strategies, practice management tips and technology trends — tailored for today’s physicians.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Medical Economics
1
Skin substitutes: Why wound care payments ‘raise major concerns about fraud, waste and abuse’
2
AMA: Physicians must lead in developing AI tools to improve patient care and workflow
3
Physicians Taking Back Medicine: Keith Smith, M.D., and the free market revolution in surgery
4